Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.
The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s.
Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories.
Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients.
The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals.
More information is available at www.questdiagnostics.com. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.
Language Assistance / Non-Discrimination Notice
Asistencia de Idiomas / Aviso de no Discriminación
語言協助 / 不歧視通知
www.QuestDiagnostics.com/home/nondiscrimination
Clear and confident health care decisions begin with questions. At Labcorp, we’re constantly in pursuit of answers.
As a global leader of innovative and comprehensive laboratory services, we help doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. We provide insights and advance science to improve health and improve lives through our unparalleled diagnostics and drug development laboratory capabilities.
Our more than 60,000 employees serve clients in over 100 countries, worked on over 80% of the new drugs approved by the FDA in 2022 and performed more than 600 million tests for patients around the world.
Learn more about Labcorp (NYSE: LH) at www.labcorp.com.
A leading provider of virtual mental health care, Talkspace provides convenient access to high-quality, evidence-based therapy, psychiatry, and self-guided support. The Talkspace network of 5,000+ licensed clinicians includes therapists and psychiatric providers with specialized knowledge of more than 150 conditions and treatment approaches. Founded in 2012, Talkspace pioneered message-based therapy, fulfilling an unmet desire of many people to text with a therapist, any time, from anywhere. We have grown into a single destination for comprehensive mental health care, including specialized therapy for individuals, couples, and teens, psychiatry and medication management, and self-guided tools and resources. All care is delivered through our fully-encrypted web and mobile platform that meets HIPAA, federal, and state regulatory requirements. More than 130 million people have access to Talkspace through their health plans for the cost of a copay or free through their employer, college or university, school district, or government agency. Making high-quality mental health support available to all is the Talkspace mission, and we’re just getting started.